Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paolo Marchetti

Showing results (231-240 of 450) with videos related to

Pageof 45
Sort By:
Current Pharmaceutical Biotechnology|May 20, 2016
H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized MedicineMarina Borro, Maurizio Simmaco, Antonio Aceti, et al.
Cancers|February 27, 2026
Non-Invasive Assessment of Treatment Response in Actinic Keratosis: A Clinically Oriented Multimodal ReviewGianluca Pistore, Luca Ambrosio, Antonio Di Guardo, et al.
Frontiers in Endocrinology|November 22, 2019
Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment NomogramsAlessandro Scoppola, Lidia Strigari, Agnese Barnabei, et al.
Cancer Immunology Research|April 28, 2018
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin PathwayIlaria Grazia Zizzari, Chiara Napoletano, Andrea Botticelli, et al.
Molecules (Basel, Switzerland)|March 11, 2023
Anticancer Activity and Molecular Mechanisms of an Ursodeoxycholic Acid Methyl Ester-Dihydroartemisinin Hybrid via a Triazole Linkage in Hepatocellular Carcinoma CellsYa-Fen Hsu, Fan-Lu Kung, Tzu-En Huang, et al.
Tumori|September 21, 2016
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and consValentina Sini, Alessandra Cassano, Domenico Corsi, et al.
Genes, Chromosomes & Cancer|January 1, 2003
New mutations and protein variants of NBS1 are identified in cancer cell linesAlessandra Tessitore, Leda Biordi, Vincenzo Flati, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 2, 2019
What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudesAlessio Cortellini, Giampiero Porzio, Vincenza Cofini, et al.
European Journal of Medicinal Chemistry|February 26, 2014
4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitorsRiccardo Baruchello, Daniele Simoni, Paolo Marchetti, et al.
Journal of Pain and Symptom Management|September 30, 2015
Epidemiology and Characteristics of Episodic Breathlessness in Advanced Cancer Patients: An Observational StudySebastiano Mercadante, Federica Aielli, Claudio Adile, et al.
Pageof 45

Showing results (231-240 of 450) with videos related to

Sort By:
Pageof 45
Current Pharmaceutical Biotechnology|May 20, 2016
H2020 and Beyond: Skip Discrepancy between Theory and Practice of Personalized Medicine. A Position Paper by the Italian Society of Personalized MedicineMarina Borro, Maurizio Simmaco, Antonio Aceti, et al.
Cancers|February 27, 2026
Non-Invasive Assessment of Treatment Response in Actinic Keratosis: A Clinically Oriented Multimodal ReviewGianluca Pistore, Luca Ambrosio, Antonio Di Guardo, et al.
Frontiers in Endocrinology|November 22, 2019
Insulin Resistance as a Risk Factor for Cutaneous Melanoma. A Case Control Study and Risk-Assessment NomogramsAlessandro Scoppola, Lidia Strigari, Agnese Barnabei, et al.
Cancer Immunology Research|April 28, 2018
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin PathwayIlaria Grazia Zizzari, Chiara Napoletano, Andrea Botticelli, et al.
Molecules (Basel, Switzerland)|March 11, 2023
Anticancer Activity and Molecular Mechanisms of an Ursodeoxycholic Acid Methyl Ester-Dihydroartemisinin Hybrid via a Triazole Linkage in Hepatocellular Carcinoma CellsYa-Fen Hsu, Fan-Lu Kung, Tzu-En Huang, et al.
Tumori|September 21, 2016
Bevacizumab as first-line treatment in HER2-negative advanced breast cancer: pros and consValentina Sini, Alessandra Cassano, Domenico Corsi, et al.
Genes, Chromosomes & Cancer|January 1, 2003
New mutations and protein variants of NBS1 are identified in cancer cell linesAlessandra Tessitore, Leda Biordi, Vincenzo Flati, et al.
Journal of Oncology Pharmacy Practice : Official Publication of the International Society of Oncology Pharmacy Practitioners|May 2, 2019
What cancer patients actually know regarding medical cannabis? A cross-sectional survey with a critical analysis of the current attitudesAlessio Cortellini, Giampiero Porzio, Vincenza Cofini, et al.
European Journal of Medicinal Chemistry|February 26, 2014
4,5,6,7-Tetrahydro-isoxazolo-[4,5-c]-pyridines as a new class of cytotoxic Hsp90 inhibitorsRiccardo Baruchello, Daniele Simoni, Paolo Marchetti, et al.
Journal of Pain and Symptom Management|September 30, 2015
Epidemiology and Characteristics of Episodic Breathlessness in Advanced Cancer Patients: An Observational StudySebastiano Mercadante, Federica Aielli, Claudio Adile, et al.
Pageof 45